• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿托伐他汀长期降低胆固醇对老年犬认知和淀粉样β处理的影响。

Changes in cognition and amyloid-β processing with long term cholesterol reduction using atorvastatin in aged dogs.

机构信息

Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 405360230, USA.

出版信息

J Alzheimers Dis. 2010;22(1):135-50. doi: 10.3233/JAD-2010-100639.

DOI:10.3233/JAD-2010-100639
PMID:20847439
Abstract

Human studies suggest either a protective role or no benefit of statins against the development of Alzheimer's disease (AD). We tested the hypothesis that statin-mediated cholesterol reduction in aged dogs, which have cognitive impairments and amyloid-β (Aβ) pathology, would improve cognition and reduce neuropathology. In a study of 12 animals, we treated dogs with 80 mg/day of atorvastatin for 14.5 months. We did not observe improvements in discrimination learning; however, there were transient impairments in reversal learning, suggesting frontal dysfunction. Spatial memory function did not change with treatment. Peripheral levels of cholesterol, LDLs, triglycerides, and HDL were significantly reduced in treated dogs. Aβ in cerebrospinal fluid and brain remained unaffected. However, β-secretase-1 (BACE1) protein levels and activity decreased and correlated with reduced brain cholesterol. Finally, lipidomic analysis revealed a significant decrease in the ratio of omega-6 to omega-3 essential fatty in temporal cortex of treated aged dogs. Aged beagles are a unique model that may provide novel insights and translational data that can predict outcomes of statin use in human clinical trials. Treatment with atorvastatin may be beneficial for brain aging by reducing BACE1 protein and omega6:omega3 ratio, however, the potential adverse cognitive outcomes reported here should be more carefully explored given their relevance to human clinical outcomes.

摘要

人类研究表明,他汀类药物对阿尔茨海默病(AD)的发展既没有保护作用,也没有益处。我们检验了这样一个假设,即在认知功能障碍和淀粉样蛋白-β(Aβ)病理学的老年犬中,他汀类药物降低胆固醇会改善认知并减少神经病理学。在一项针对 12 只动物的研究中,我们用 80 毫克/天的阿托伐他汀治疗狗 14.5 个月。我们没有观察到辨别学习的改善;然而,在反转学习中存在短暂的损伤,这表明额叶功能障碍。治疗并未改变空间记忆功能。治疗犬的外周胆固醇、LDL、甘油三酯和 HDL 水平显著降低。脑脊液和大脑中的 Aβ 仍然不受影响。然而,β-分泌酶-1(BACE1)蛋白水平和活性降低,与大脑胆固醇减少相关。最后,脂质组学分析显示,治疗的老年犬颞叶皮质中ω-6 到 ω-3 必需脂肪酸的比例显著降低。老年比格犬是一种独特的模型,它可能提供新的见解和转化数据,这些数据可以预测他汀类药物在人类临床试验中的应用结果。阿托伐他汀治疗可能通过降低 BACE1 蛋白和 ω6:ω3 比值对大脑衰老有益,然而,鉴于其与人类临床结果的相关性,这里报告的潜在认知不良后果应更仔细地探索。

相似文献

1
Changes in cognition and amyloid-β processing with long term cholesterol reduction using atorvastatin in aged dogs.阿托伐他汀长期降低胆固醇对老年犬认知和淀粉样β处理的影响。
J Alzheimers Dis. 2010;22(1):135-50. doi: 10.3233/JAD-2010-100639.
2
Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice.阿托伐他汀和匹伐他汀可改善认知功能,减少老年 APP 小鼠的老年斑和磷酸化 tau。
Brain Res. 2011 Jan 31;1371:161-70. doi: 10.1016/j.brainres.2010.11.067. Epub 2010 Nov 25.
3
Statin therapy for Alzheimer's disease: will it work?用于治疗阿尔茨海默病的他汀类药物疗法:会有效吗?
J Mol Neurosci. 2002 Aug-Oct;19(1-2):155-61. doi: 10.1007/s12031-002-0026-2.
4
Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease.胆红素还原酶-A:阿托伐他汀在阿尔茨海默病犬临床前模型中的一个新的药物靶点。
J Neurochem. 2012 Jan;120(1):135-46. doi: 10.1111/j.1471-4159.2011.07538.x. Epub 2011 Nov 9.
5
The influence of simvastatin, atorvastatin and high-cholesterol diet on acetylcholinesterase activity, amyloid beta and cholesterol synthesis in rat brain.辛伐他汀、阿托伐他汀及高胆固醇饮食对大鼠脑内乙酰胆碱酯酶活性、β-淀粉样蛋白及胆固醇合成的影响
Steroids. 2009 Jan;74(1):13-9. doi: 10.1016/j.steroids.2008.08.007. Epub 2008 Sep 5.
6
Cholesterol, copper and Abeta in controls, MCI, AD and the AD cholesterol-lowering treatment trial (ADCLT).对照组、轻度认知障碍(MCI)、阿尔茨海默病(AD)及AD降胆固醇治疗试验(ADCLT)中的胆固醇、铜和β淀粉样蛋白
Curr Alzheimer Res. 2005 Dec;2(5):527-39. doi: 10.2174/156720505774932296.
7
Atorvastatin-induced activation of Alzheimer's alpha secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding.阿托伐他汀诱导的阿尔茨海默病α分泌酶激活对蛋白质磷酸化调节的胞外域脱落的标准抑制剂具有抗性。
J Neurochem. 2004 Aug;90(4):1005-10. doi: 10.1111/j.1471-4159.2004.02521.x.
8
The effect of exogenous cholesterol and lipid-modulating agents on enterocytic amyloid-beta abundance.外源性胆固醇和脂质调节因子对肠细胞淀粉样β蛋白丰度的影响。
Br J Nutr. 2009 Feb;101(3):340-7. doi: 10.1017/S0007114508012269. Epub 2008 Jul 17.
9
Statins have therapeutic potential for the treatment of Alzheimer's disease, likely via protection of the neurovascular unit in the AD brain.他汀类药物具有治疗阿尔茨海默病的潜力,可能通过保护 AD 大脑中的神经血管单元来实现。
J Neurol Sci. 2012 Nov 15;322(1-2):59-63. doi: 10.1016/j.jns.2012.06.011. Epub 2012 Jul 15.
10
Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis.阿托伐他汀对长期透析患者低密度脂蛋白胆固醇表型及C反应蛋白水平的影响
Pharmacotherapy. 2005 Mar;25(3):335-44. doi: 10.1592/phco.25.3.335.61599.

引用本文的文献

1
Correlation of atorvastatin with subjective memory deficits: a study from the NHANES and FAERS databases.阿托伐他汀与主观记忆缺陷的相关性:一项来自美国国家健康与营养检查调查(NHANES)和药品不良事件报告系统(FAERS)数据库的研究。
Front Neurol. 2025 Mar 10;16:1526959. doi: 10.3389/fneur.2025.1526959. eCollection 2025.
2
Neuroprotective Effects of the Amylin Analog, Pramlintide, on Alzheimer's Disease Are Associated with Oxidative Stress Regulation Mechanisms.类胰淀素类似物普兰林肽对阿尔茨海默病的神经保护作用与氧化应激调节机制有关。
J Alzheimers Dis. 2019;69(1):157-168. doi: 10.3233/JAD-180421.
3
Atorvastatin Attenuates Cognitive Deficits and Neuroinflammation Induced by Aβ Involving Modulation of TLR4/TRAF6/NF-κB Pathway.
阿托伐他汀通过调节 TLR4/TRAF6/NF-κB 通路减轻 Aβ 诱导的认知障碍和神经炎症。
J Mol Neurosci. 2018 Mar;64(3):363-373. doi: 10.1007/s12031-018-1032-3. Epub 2018 Feb 7.
4
Statins and the Brain: More than Lipid Lowering Agents?他汀类药物与大脑:不仅仅是降脂药物?
Curr Neuropharmacol. 2019;17(1):59-83. doi: 10.2174/1570159X15666170703101816.
5
Aβ vaccination in combination with behavioral enrichment in aged beagles: effects on cognition, Aβ, and microhemorrhages.老年比格犬中Aβ疫苗接种与行为强化相结合:对认知、Aβ和微出血的影响。
Neurobiol Aging. 2017 Jan;49:86-99. doi: 10.1016/j.neurobiolaging.2016.09.007. Epub 2016 Sep 26.
6
Lovastatin Differentially Affects Neuronal Cholesterol and Amyloid-β Production in vivo and in vitro.洛伐他汀在体内和体外对神经元胆固醇及β-淀粉样蛋白生成有不同影响。
CNS Neurosci Ther. 2015 Aug;21(8):631-41. doi: 10.1111/cns.12420. Epub 2015 Jun 20.
7
Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer's Disease?微小RNA是代谢综合征与阿尔茨海默病之间的分子纽带吗?
Mol Neurobiol. 2016 May;53(4):2320-38. doi: 10.1007/s12035-015-9201-7. Epub 2015 May 15.
8
Biliverdin Reductase-A correlates with inducible nitric oxide synthasein in atorvastatin treated aged canine brain.阿托伐他汀治疗老年犬脑中胆红素还原酶-A 与诱导型一氧化氮合酶相关。
Neural Regen Res. 2013 Jul 25;8(21):1925-37. doi: 10.3969/j.issn.1673-5374.2013.21.001.
9
Possible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factors.他汀类药物对中年阿尔茨海默病的潜在影响:与遗传和非遗传风险因素的相互作用。
Front Aging Neurosci. 2014 Apr 23;6:71. doi: 10.3389/fnagi.2014.00071. eCollection 2014.
10
Prevention approaches in a preclinical canine model of Alzheimer's disease: benefits and challenges.阿尔茨海默病临床前犬模型中的预防方法:益处与挑战。
Front Pharmacol. 2014 Mar 21;5:47. doi: 10.3389/fphar.2014.00047. eCollection 2014.